242
Views
4
CrossRef citations to date
0
Altmetric
Letters

Significant reduction in proteinuria after treatment with tafamidis

, , , , , , , & show all
 

Disclosure statement

Dr. Juan Buades has been consultant for Pfizer and Alnylam and participates in Medical Advisory Boards, Scientific Meetings and protocols. The other authors report no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.